Westlake Landmark office park
Westlake Village, CA
Full Time Employees: 153
|Dr. Michael E. Castagna Pharm.D.||CEO & Director||378.41k||N/A||41|
|Dr. David B. Thomson Ph.D., J.D.||Corp. VP, Gen. Counsel & Corp. Sec.||458.68k||424.8k||51|
|Mr. Steven Binder||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Joseph Kocinsky||Chief Technology Officer||N/A||N/A||54|
|Ms. Courtney Barton||Chief Compliance Officer and VP||N/A||N/A||N/A|
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes diseases in the United States. Its approved product is Afrezza, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. The company was founded in 1991 and is headquartered in Westlake Village, California.
MannKind Corporation’s ISS Governance QualityScore as of January 1, 2018 is 6. The pillar scores are Audit: 5; Board: 4; Shareholder Rights: 3; Compensation: 5.